Objective: Traumatic brain injury (TBI) frequently results in poor outcome, suggesting that new approaches are needed. We hypothesized that a patient-specific in silico computer model of intracranial pressure (ICP) dynamics may predict the ICP response to therapy.
T raumatic brain injury (TBI) is a leading cause of death and disability in children younger than 18 years, causing more than 50% of all childhood deaths in the United States. Each year, more than 150,000 pediatric brain injuries result in about 7000 deaths and 29,000 children with new, permanent disabilities. The death rate for severe TBI (defined as a Glasgow Coma Scale score Յ8) remains between 30% and 45% at major children's hospitals (1, 2) . A published evidence-based medicine review reports that elevated intracranial pressure (ICP) is a main determinant of outcome following TBI and is strongly correlated with both death and disability (3) . The underlying mechanism is that persistent elevated ICP leads to reduced blood flow, which can result in insufficient tissue perfusion (ischemia), secondary injuries, and generally poor outcomes.
Despite the availability of many treatment options for reducing elevated ICP (defined as Ն20 mm Hg) (3), poor outcomes frequently result, often because of elevated ICP that is unresponsive to therapy. Treatment options for severe TBI include draining cerebral spinal fluid (CSF) via a ventriculostomy catheter, raising the head-of-bed (HOB) elevation to 30°to promote jugular venous drainage, and inducing mild hyperventilation (2, 4, 5) . The underlying pathophysiologic mechanisms governing ICP regulation and the mechanisms by which various treatments affect ICP remain only partially understood (6) . It is known, for example, that HOB directly impacts arterial and venous pressure by changing the elevation of the head relative to the heart, which changes the pressures in cerebral vessels. The mechanism by which changes in respiration and PaCO 2 affect ICP is more complex and results in reduced intracranial blood volume and decreased ICP. These relationships are discussed further in the methods.
We suggest that new approaches are needed to help improve diagnosis, treatment, and outcome following severe TBI. One candidate approach is to develop and utilize patient-specific in silico (i.e., computer) models of ICP dynamics that "learn" from direct patient data and then may be queried to predict the likely ICP response to a specific therapeutic intervention. Computer models of ICP dynamics that match historical data almost exactly have been reported in the literature (7, 8) . However, there are no reports in the literature of using these models to predict an individual patient response, and it is not known whether computer models are capable of doing this. We believe that predicting individual patient response requires annotated data indicating the exact timing of treatment changes as well as a robust model that incorporates a database of pathologic and treatment variables.
Therefore, we hypothesized that 1) we could build a novel in silico computer model of dynamic ICP changes that could accurately reproduce observed ICP signals recorded prospectively with the timing of clinical interventions being carefully annotated and 2) such a model could be used to predict ICP changes in future sessions in response to interventions different from those used to calibrate the model.
The purpose of the study was to test these hypotheses for two specific treatment options: changes in the HOB and the induction of mild hyperventilation by changing the respiration rate (RR). These treatment options were chosen because they are noninvasive, easily adjusted in terms of degree, and easily reversed if necessary for subject safety. Physiologic Signal Data Acquisition and Physiologic Challenge Protocol. Physiologic signals and parametric data were recorded continuously, and precise annotations were captured regarding the exact timing of protocol events using the Physiologic Data Acquisition System (PDAS) as previously described (9) . In many cases, multiple sessions were recorded on different days. Signals recorded included electrocardiogram, respiration, arterial blood pressure, ICP, and arterial oxygen saturation. The ICP signal was captured at 125 Hz. Because the model sought to capture only the time behavior of mean ICP, the high-frequency components of the signal were ignored (10) . Therefore, the data were decimated and a low-pass filter was applied, yielding smoothed data at a sample rate of 5 Hz, which removed most of the pulsatile component. These data were still noticeably more complex than the output of the model, but preliminary research showed that further simplification threatened to remove important features of the ICP signal.
METHODS
The response of the subject to the physiologic challenges was used to perturb the system from a resting or steady state and thus estimate patient-specific parameters to build a computer model of ICP dynamics (the "test" data set). The patient-specific dynamic computer model was then used to predict the patient's response to subsequent challenges, both at later time points within the same session and also during subsequent sessions (the "validation" data sets).
The two physiologic challenges listed below were selected as they represent commonly occurring changes in this patient population and were judged a priori to be relatively mild when compared with other therapeutic interventions and would most often produce a physiologic mild response. The challenges were administered in random order over a 2to 3-hour period for as long as a subject had an ICP monitoring device in place and was clinically stable as determined by the attending intensive care unit physician. The challenges included the following 1. Altering the HOB elevation in random order between 0°and 40°in increments or decrements of 10°at 10-minute intervals and 2. Increasing minute ventilation (hyperventilation) or decreasing minute ventilation (hypoventilation), in random order, while keeping the tidal volume fixed to achieve a ⌬ETCO 2 ϭ Ϯ3-4 mm Hg from baseline values. At each target ETCO 2 , PaCO 2 was checked via arterial blood gas to ensure that the ETCO 2 reflected accurate changes in actual PaCO 2 . If not, minute ventilation was further adjusted, and ETCO 2 and PaCO 2 were rechecked at each target level of hyperventilation and hypoventilation was maintained for 15 minutes.
The protocol was stopped for the day if a physiologic challenge induced clinical deterioration as defined by ICP Ͼ25 mm Hg for Ͼ5 minutes, cerebral perfusion pressure Ͻ40 mm Hg, systemic hypotension Ͻ2 SD below normal age, or Spo 2 Ͻ90%.
ICP Dynamic Model. The model of ICP dynamics used in this study was patterned after models previously reported by our research group (11) (12) (13) . Because the underlying physiology is very complex and not completely understood, the mathematical model is necessarily highly simplified. The model consisted of six differential (rate) equations for three blood volume compartments plus the CSF fluid volume in aggregate, the brain tissue volume (which could be normal or edematous), and when appropriate, an intracranial or extracranial hematoma volume. The pressure in each compartment was calculated by the model based on its instantaneous volume and its compliance; and the calculated pressure can be easily compared with the observed data from the patient.
The numerical integration algorithm used a variable time step capable of computing both high-frequency dynamics (Ͼ1 Hz) and lowfrequency dynamics (Ͻ0.01 Hz). However, the only mechanisms designed into the model had time constants varying from a few seconds to a few minutes. Regarding the impact of the protocol interventions, the model is consistent with the mechanisms described in Figure 1 .
The immediate impact of changing the angle, , of the HOB is a change in both arterial pressure and ICP by an amount that is directly proportional to sin (⌬), as shown in Figure 1 . What happens after this immediate response is complex and not reflected in Figure 1 . The model does, however, reflect some of this complexity.
The effects of changing minute ventilation are much more complex. Minute ventilation is the product of respiratory rate, RR, and tidal volume. As tidal volume was held constant during all the physiologic challenge periods, Figure 1 . Impact of head-of-bed (HOB) elevation and respiratory rate (RR) changes on intracranial pressure (ICP).
we varied RR to produce a change in minute ventilation. Changes in RR directly affect PaCO 2 , and PaCO 2 reactivity is another complex feedback loop in our model. An increase in RR causes a decrease in PaCO 2 with a subsequent increase in capillary resistance due to increased smooth muscle tone, and hence a reduced cerebral blood flow. The increase in capillary resistance decreases the arterial-tocapillary flow to match the indicated flow, and thus affects cerebral arterial blood volume. Indicated flow is modeled as a baseline flow plus or minus an adjustment. The adjustment is proportional to the difference between baseline ETCO 2 and current ETCO 2 .
The model was implemented in MATLAB Simulink Version 7 (The MathWorks, Natick, MA). The Appendix contains additional information about the ICP dynamic model.
Parameter Estimation. Parameter estimation refers to the mathematical process of adjusting the parameters of the model to achieve an objective, i.e., to minimize the error between the observed data and the data generated by the model. The primary inputs to the ICP dynamic model were the random changes to the HOB and minute ventilation specified by the physiologic challenge protocol. These changes entered the model as step functions at the times specified in the clinical annotations to the data. There were no other time-based inputs to the model; all other parameters were either initial values or constants. Although the protocol sessions provided multiple physiologic signals for each subject, the only measurement used by the estimation process was the ICP signal, which was compared with the ICP computed by the model to determine model fitness for specific sets of parameter values.
Besides the state variables (volumes) and inputs (the timing of the physiologic challenge events), the other dynamic quantities in the model were the parameters adjusted during the model identification process. These physiologic parameters were estimated for each subject based on the measured ICP response. The estimation was done by varying the parameters with the objective to minimize the sum of squared differences between the ICP response calculated by the model and the observed ICP data, ignoring some outliers (for example, at the very beginning of a simulation run when the system of equations has sometimes not yet stabilized, or where the observed ICP data showed likely measurement discrepancies). The lsqcurvefit nonlinear optimization algorithm in MATLAB was used and was specified to run either until the change in the sum of the squared errors fell below a certain tolerance (0.1 in most cases) or until a certain number of iterations had been completed (typically 41 or 51 iterations, depending on the number of parameters being modified). The algorithm required many simulations of the model to be run, each with a different set of parameter values. Each set of parameter values was chosen by the algorithm based on the results of prior runs, in its quest to reduce model fitness error. As most model runs took a minute or longer to compute, the entire nonlinear optimization process often took one or more hours to complete for a given case (subject/session).
The initial parameter values were derived from the medical literature of reported ICP computer models (14) . The procedure for estimating parameter values that minimized the difference between the model-calculated ICP values over time and the observed ICP signal data (referred to as the "best fit") is shown in Figure 2 . In each case, the nonlinear optimization algorithm was configured to vary between four and eight parameters. The parameters were chosen from the following group based on sensitivity testing and their applicability to the challenges prescribed in the challenge protocol: autoregulation factor (smooth muscle compliance effect), basal cranial volume, CSF drainage rate, hematoma increase rate, ⌬ pressure time constant (a smoothing parameter associated with HOB elevation change), ETCO 2 time constant (a smoothing parameter associated with RR changes), smooth muscle gain (a multiplicative factor related to the impact of smooth muscle tension), systemic venous pressure, "baseline" ICP, and the pressure volume index.
Statistical Analysis: Prediction Assessment. To present the results from computergenerated predictions and compare them to observed data, we chose to use mean absolute deviation (MAD) and mean absolute error (MAE). MAD describes the degree to which data in a sample vary from their mean. As indicated in Equation 1, MAD is the average of the absolute differences between the individual observed data points and the mean of the observations. Similar to MAD, MAE, as indicated in Equation 2, is the average absolute difference between the model calculated values and the observed values. Besides being conceptually simpler, MAD and MAE also do not give more "weight" to large discrepancies, which are sometimes present in the data due to data collection "glitches." Such glitches should not unduly influence the calculation of errors and deviations from the mean. Note, however, that the parameter estimation pro-cess described in Figure 2 minimized the root mean squared (RMS) error as is typically done.
Dividing the error (MAE) by the average deviation (MAD) is a useful way to scale or standardize both model fit error and model prediction error. In the model fitness situation, when MAE/MAD Ͼ1, ICP calculated by the model is less accurate than simply using the mean ICP value as the model for ICP over time. Figure 3 portrays the methods used to assess the prediction capability of the computer model. First, session-specific parameters were estimated using the process described earlier in Figure 2 , and the MAE for each session was computed to determine how accurately the model could reproduce the observed ICP. Baseline values were determined for each parameter by studying the session-specific values that had been estimated for a given parameter. A single most representative value was then chosen. In some cases, this was the mean value; in other cases, the median value was chosen. These baseline parameter values were then used to estimate the ICP trajectory for each session, and the errors in these estimates were computed to determine the degree of improvement that was achieved by estimating session-specific parameters.
To determine how well the model was able to predict ICP response, two analyses were performed. First, the available subject data were reviewed to determine which sessions contained sufficient data to partition them into two segments, A and B, to conduct a "within" session analysis, such that Segment A could be used for estimation and Segment B for prediction. The criteria used for partitioning were that the session contained at least two protocol events, with a sufficient stationary period (Ն8 minutes) between the end of Segment A and the start of Segment B such that the segments can be treated as independent. For sessions that could be partitioned accordingly, the best fit model parameters for Segment A were estimated, the resulting session/segment-specific model was used to predict the ICP responses in Segment B, and the prediction MAE was computed.
The second prediction analysis was a "between" session analysis for subjects with multiple sessions. This analysis used the sessionspecific parameter values from one or more early sessions to predict the ICP responses in later sessions and the MAEs were computed for these predictions. Parameters from multi-
Parameter estimation process using an optimization algorithm to find the "best fit" parameter values. HOB, head-of-bed; RR, respiratory rate; ICP, intracranial pressure; RMS, root mean square. ple sessions were aggregated by taking their simple mean.
RESULTS
We studied nine patients with severe TBI undergoing ICP monitoring (7 M/2 F, age range 3-16 years). The mean Glasgow Coma Scale Score on admission was 5.2 (range 3-8). All of the patients survived. Table 1 shows specific information regarding each session, including its length, the various protocol events that occurred, the mean ICP, and the ICP MAD. Also shown is the error in modelcalculated ICP for two cases: 1) using the average parameter values and 2) using the session-specific parameter values. Summary rows pertaining to multiple sessions were computed as weighted means based on session length. Table 1 indicates that using baseline parameter values does not provide accurate predictions, with an average MAE in excess of 7 mm Hg. Because the average MAD for these sessions was about 3 mm Hg, a naïve model that assumed ICP would simply remain constant at its mean value for the entire session would be considerably more accurate. The results when using patient-specific parameter values were much better, with a mean MAE of 1.86 mm Hg. The ratio of MAE to MAD for these models is less than one on average for eight of nine subjects, although three out of 24 sessions had an MAE/MAD Ͼ1. On the other hand, the weighted average MAE/MAD for six of the nine subjects was at or below 0.5. To aggregate across sessions, the data points were weighted by the length of the session. The modeled response is very close to the observed response in most cases. Some notable exceptions were found in the following: Patient 007 (Plot Nos. 10, 11, 12) , where there was a mechanical artifact in the observed ICP signal; Plot No. 10 where the parameter estimation process found parameters that effectively neutralized the "normal" response logic, but the model was not capable ͓by design͔ of being calibrated to produce the opposite response; Patient 004 (Plot No. 3) where the model calculated response at the end of the session was much greater than the observed response because the parameters were chosen to match an early and very pronounced response to a similar change in HOB; and Patient 207 (Plot No. 24) where the model calculated ICP variations were similar to observed variations in some respects, but not in others and were found to be a result of external stimulus from the subject's parents.
Plot 20, Patient 202 shows intracranial hypertension between minutes 35 and 60. The protocol was put on hold at t ϭ 32 after a CO 2 challenge to allow for a clinical intervention. This clinical intervention (not the protocol) induced a significant elevation in ICP; consequently, the protocol was suspended and not recommenced that day. Table 2 provides additional information regarding the error (MAE) in the modeled ICP for the patient-specific models, aggregated in several ways: by pa-tient, by type of challenge during the session, by the number of challenges, by the length of the session, and by the mean ICP for the session.
This table clearly shows the two patients whose responses were difficult to capture in the model (007 and 207), and it also shows that the model error for the other seven patients was considerably smaller. Although the grouping of RRonly sessions indicated much lower error, there were only three sessions in this group, none of which involved the two "problematic" patients. As might be expected, the error in modeled ICP was larger for sessions that were longer or contained more challenges. The error in modeled ICP was also larger when the mean ICP for the session was moderate rather than being either low or high. This latter result was not anticipated. Table 3 describes the 22 situations that were amenable to predicting the response within a given session. Of the 24 sessions included in this study, 19 contained sufficient data to be able to use an early segment of the session (the parameter estimation segment, A) to estimate the ICP response to challenges in a later segment of the session (the predicted segment, B). Figure 5 shows the results graphically for four selected cases.
To obtain the data in Table 3 , three of the sessions shown in Table 1 and Figure  4 were subdivided into an HOB segment and an RR segment, both of which contained sufficient data to be able to conduct a within-segment prediction test for the HOB response separately from the RR response, labeled as HOB and RR, respectively, in Table 3 . Consequently, 22 segments were analyzed for within-session prediction. The average ICP in Segment A and Segment B were nearly equal (ϳ16 mm Hg). The overall MAD in both segments was also nearly the same (ϳ2.5 mm Hg). MAE and the ratio MAE/MAD are shown for both the estimation (or training) segment and the predicted segment. The weighted average MAE for the predicted ICP in Segment B was 4.56 mm Hg, despite the fact that the weighted average MAE for training segment was 2.11 mm Hg, which is less than the weighted average MAD of 2.58 mm Hg. The high weighted average prediction MAE was influenced by four segments with MAE Ͼ8 mm Hg. Offsetting these high values were five segments with MAE ϳ1 mm Hg. The MAE for most of the remaining 13 segments was between 2 and 4 mm Hg. Figure 4 shows the error in the predicted ICP versus the best fit model-calculated ICP. Plot 1 in Figure 5 compared with Plot 3 in Figure 4 shows that when the model parameters are optimized for Segment A only, the calculated response to the change in RR at time 43 was even more exaggerated than shown in Figure 4 . Plot 2 in Figure 5 compared with Plot 9 in Figure 4 shows a case where the shape of the response is correctly predicted, but shows a consistent bias in the predicted ICP. Plot 3 in Figure 5 compared with Plot 14 in Figure 4 shows an exaggerated slope in the predicted ICP, and Plot 4 in Figure 4 compared with Plot 23 in Figure 4 shows the correct shape of the response but with an offset. Table 4 shows the results of using the estimated parameters from one or more prior sessions to predict the patient's ICP response during subsequent sessions. A total of 31 cases were tested, involving five different patients. For three patients, there were four sessions, which enabled six cases to be tested (1 3 2, 1 3 3, 1 3 4, 1 ϩ 2 3 3, 1 ϩ 2 3 4, and 1 ϩ 2ϩ3 3 4). One patient had three sessions, so that three cases could be tested; and one patient had five sessions, so that 10 cases could be tested. The MAE in the predicted ICP for these tests in aggregate was 6.74 mm Hg. For five of the 10 sessions that were predicted by aggregating parameter estimates from multiple sessions, the prediction error was reduced when parameter estimates from multiple sessions were utilized. However, for four other sessions, the error in predicted ICP increased when parameter estimates from multiple sessions were aggregated. In the final case, the error in predicted ICP did not change.
DISCUSSION
Our main findings were that a protocol for collecting physiologic challenge data in subjects with severe TBI is feasible. Our in silico dynamic ICP model was able to consistently and accurately reproduce the subject's ICP response to changes in RR and HOB (6 of 9 patients, 17 of 24 sessions). Furthermore, we demonstrated a limited degree of success at predicting future ICP changes within a session (1 of 9 patients, 6 of 22 sessions) and between sessions (3 of 31 cases).
One potential advantage for such an approach would be to reduce risk. Therapies intended to reduce ICP do not al- Table 1 showing observed and modeled intracranial pressure (ICP) using individually fit parameter values. The number for individual plot corresponds to the row in Table 1 . The observed ICP waveform is the green jagged trace. The modeled ICP is the nonjagged blue trace. The dotted and dashed traces at the bottom show changes in the head-of-bed (HOB) and ventilation rate, respectively.
ways work as expected-the cerebral perfusion pressure might decrease and thereby increase the risk of cerebral ischemia, or, benefits might be short-lived, with long-term outcomes that are actu-ally worse than without treatment. Therefore, it would be useful to be able to predict a specific patient's most likely response to different therapies before they are administered, and thereby determine how to achieve the best therapeutic response with the least adverse effect. Over the past 30 years, a variety of computer models for calculating ICP dynamics have been published in the bio- MAE, mean absolute error; HOB, head-of-bed; RR, respiration rate; ICP, intracranial pressure. medical engineering literature (15, 16) . These models use differential equations to calculate the pressure at different points within the system, taking into account the blood vessel and anatomical compartment volumes and compliances. Although interesting mathematical results and pathophysiologic insights have been gained from these models, their impact on clinical practice has been limited.
Reasons for this limited impact may include the complexity of the models and the limited range of bedside in vivo clinical scenarios represented. Researchers have attempted to address these limitations by simplifying their models (17) and by adding clinically meaningful functionality. Some parameter estimates derived from the laboratory data and/or clinical data have been reported, but much of the necessary data remain difficult to obtain. Researchers have calibrated models to fit patient-specific data (7, 8, (11) (12) (13) (17) (18) (19) (20) (21) and excellent results have been reported in some cases (8, 21) . However, actual prediction of patient-specific ICP response to therapies or other interventions has not been reported. Thus, we suggest that use of an approach similar to ours, which incorporates detailed and lengthy data recordings plus clinically annotated information (e.g., including the exact timing for medications, CSF drainage, ventilator adjustments), will be required for any ICP model to be clinically useful and will almost certainly be needed if models are to be used to predict response to therapy. The model used in this research is similar in many ways to previously reported dynamic ICP models by our research group in that it considers the cranial vault to contain the brain parenchyma plus several fluid "compartments" that together are constrained not to exceed the total cranial volume (11) (12) (13) . The fluid compartments include the arterial blood volume, capillary blood volume, venous blood volume, CSF volume, the brain volume, and "other" volume. Other volume could be an additional volume resulting from epidural or subdural hematoma, or an intraparenchymal hemorrhage, and may not be present in some patients. The brain volume can be either constant or variable, based on the presence and degree of cerebral edema.
Consistent with findings reported by prior investigators (15, 17) , autoregulation is modeled as a feedback loop that causes the cerebral vasculature to dilate or constrict, taking into account control limits that are nonlinear and asymmetric. The control logic in our model acts only on the flow of blood from the arterial compartment to the capillary bed. The control logic is proportional and has enough "gain" that it can easily maintain the required flow under normal conditions. However, if the venous or arterial volumes are severely reduced, as is often the case with severe TBI, the associated nonlinear increases in resistance can "overwhelm" the model's simplified control logic in an unrealistic fashion.
The main difference between our ICP dynamic model and other models reported in the literature is that the state variables are modeled as volumes rather than pressures, and the fluid flows into and out of each compartment are clearly identified and represented. This approach is more intuitive, and it may facilitate the representation of in vivo pathophysiologic processes. Blood pressures are computed from the volumes of the blood compartments and their associated compliances. ICP is computed using the total intracranial volume and the pressure volume index (11) (12) (13) .
Our model incorporates logic associated with severe TBI pathophysiology, including the "other" volume mentioned earlier, ongoing intracranial bleeding, and focal or generalized cerebral edema. The model also incorporates common therapeutic interventions such as elevation of the HOB and changing the minute ventilation to induce mild hyperventilation (decreasing PaCO 2 to 33-35 mm Hg). We have previously shown that the behavior of our model was qualitatively correct (11, 12) , and we were able to manually calibrate the model so that it replicated retrospective clinical data from two prior subject-specific cases (13) . Preliminary parameter estimation results were reported in Ref. 12. Further details regarding the model are provided in the Appendix.
Whether the length of the sessions influence the prediction error is not addressed in this study, because, as shown in Table 2 , the modeled ICP error is positively correlated with the length of the session. Future work will investigate possible correlations between prediction error and (a) the length of the session or segment used to estimate model parameters and (b) the length of the predicted session or segment.
Study Limitations. The mixed results reported are likely to be due in part to the fact that the intracranial system is not stationary, meaning that there are very few aspects of the system that are truly constant. Because many of the relevant parameters cannot be (or at least have not been) measured, it can be very difficult to assess the degree to which the lack of stationarity has influenced the results.
At the same time, it is very likely that the ICP dynamic model used in this study may be too simplified to accurately predict response to therapy. The model was designed to reflect the initial and shortterm physiologic responses (seconds to a few minutes) and lacks the mechanisms that would be needed to reproduce the lower frequency (long term) responses. More complex models have been reported in the literature, and such models have been shown to be able to match clinical data even better than the results shown in Figure 4 . For example, Ursino et al (8) showed model-calculated ICP dynamics that were nearly identical to the observed data. Still, the results shown in Figure 4 indicate that the ICP dynamic model used in this study is capable of repeatedly calculating ICP responses to HOB and RR changes that are very similar to those seen in the clinical recordings.
Additionally, we may not have collected all pertinent clinically annotated data nor accurately incorporated these data into the model. Clearly, in a clinical situation all factors that influence ICP cannot be controlled (e.g., bedside visitors to the intensive care unit, coughing, administration of scheduled medications). Incorporating additional data regarding cerebral edema or intracranial or extracranial hematoma or hemorrhage from computed tomography or magnetic resonance imaging scans may also be of value, and using data from other organ systems (e.g., blood pressure, heart rate, arterial oxygen saturation) and other methods for neuromonitoring (e.g., near infrared spectroscopy, brain tissue oxygenation) may also improve either the model or the predictive capabilities. However, although it may be possible to improve overall prediction accuracy by disregarding data that are anamolous or counter to known physiology, if there is to be any hope of simulating real clinical scenarios, this type of problematic data must be accommodated and incorporated somehow into the model.
The current fitting process may require in excess of 20 minutes, whereas making a prediction from the in silico model takes less than a minute. Therefore, with a faster computer and more dedicated model logic, both the fitting and prediction could be accomplished in Ͻ1 minute resulting in a model that could potentially be clinically useful at the bedside.
Finally, although the physiologic challenges used in the study protocol were judged a priori to be mild and likely to elicit similarly mild responses, there were instances when the ICP increased. Although these increases were not beyond our defined adverse event thresholds, these findings will need to be carefully evaluated for safety and risk:benefit ratio in future clinical research protocols in this patient population. A specific concern, for example, is the period of elevated ICP shown in Figure 4 , plot 20 (P202S4). This elevated ICP occurred as a result of a clinical intervention and not the study protocol. To allow for this clinical intervention, the research protocol was stopped immediately after the CO 2 challenge at t ϭ 32 minutes, when the ICP was 15 mm Hg and the patient was stable. The bed was lowered to 10 degrees for the clinical intervention to take place, which caused the ICP to rise to 30 mm Hg. Data collection was continued to avoid loss of information. Clinical and nursing staff not involved in the research study directed therapy during this clinical intervention. ICP-lowering therapies were given, and the intracranial hypertension was resolved (at a point in time beyond the data collection period). The research protocol was not resumed that day.
CONCLUSIONS
We have demonstrated a novel method for data collection, a new dynamic ICP model, and an initial attempt to use the model to predict a subject's response to therapy. The in silico ICP model with session-specific parameters accurately reproduced observed ICP response to changes in HOB and RR. We demonstrated modest success at predicting future ICP within a session and to a lesser extent between sessions. We suggest that this area of research be explored in the future with an emphasis on building models that more completely reflect the underlying physiology and that incorporate even finer and more granular clinical data.
